Evidence map›Paper›PMID 42608700›Full record

ArticleBiology direct2026

STING‑regulated Ca²⁺-TGF‑β axis drives airway remodeling and lung function decline in asthma: a multi‑omics mechanistic study.

Zhiqin Zhu, Qingao Xiao, Runjin Cai, Enyu Qi, Xiaoxiao Gong, Jiale Tang, Xiaozhao Li, Juntao Feng

Abstract read
In one paragraph

Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiqin Zhu *Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Qingao Xiao *Department of Radiology, Xiangya Hospital, Central South University, Changsha, 410005, China.
Runjin CaiDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Enyu QiDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Xiaoxiao GongDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Jiale TangDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Xiaozhao LiNational Clinical Research Center for Geriatric Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. lixiaozhao@csu.edu.cn.
Juntao FengDepartment of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. jtfeng1976@csu.edu.cn.

Funding

National Natural Science Foundation of China Nos. 82270033 and 82470740
6 · The paper itself

Abstract

backgroundThe progressive lung function decline in severe asthma is poorly explained by traditional inflammation‑centered paradigms. Calcium (Ca²⁺) dysregulation and transforming growth factor‑β (TGF‑β) signaling have been implicated, but the molecular link between them and their upstream regulators remain elusive.

methodsWe integrated clinical CT imaging, proteomics (6 asthma vs. 6 healthy controls), public transcriptomic data (GSE63142, GSE68479), single‑cell RNA‑sequencing (GSE193816, GSE185048), and functional studies in STING knockout mice and airway epithelial cells. GO and KEGG enrichment, LASSO regression, Spearman correlation, immunohistochemistry, immunofluorescence, co‑immunoprecipitation, western blot, mitochondrial function assays (MitoSOX/JC‑1), Fura‑2 calcium imaging, RNA‑seq and ELISA were used to systematically evaluate the role of the STING‑PPM1F‑Ca²⁺‑TGF‑β axis in asthma airway remodeling.

resultsUsing logistic regression, we found that disease severity, age, pulmonary function parameters and eosinophil count independently predicted the presence of tracheal cartilage calcification, with the model achieving excellent discrimination (AUC > 0.92). Proteomics identified PPM1F, CAMK2G, MICU2 and CIB1 as key calcium‑metabolism proteins co‑enriched in calcium signaling and TGF‑β pathways; PPM1F expression strongly correlated with reduced FEV₁% (r = - 0.94, p = 0.005) and recurrent exacerbation risk (p < 0.01). Functionally, OVA induced time‑dependent mitochondrial ROS elevation and membrane potential dissipation, triggered cytosolic mtDNA release, and activated STING downstream p‑TBK1 signaling. STING activation directly mobilized intracellular Ca²⁺ via both store release and extracellular influx, as demonstrated by Fura‑2 imaging. STING knockout or silencing abolished OVA‑induced PPM1F upregulation and TGF‑β/Smad activation, and attenuated airway pathology. Co‑immunoprecipitation confirmed direct PPM1F‑TGF‑β physical interaction. Single‑cell transcriptomics revealed SFTPC⁺ epithelial cell expansion and high NKX2‑1/FOXA2 activity; multiplex immunofluorescence further identified SCGB1A1⁺SFTPC⁺ double‑positive cells in asthmatic airways, suggesting a potential phenotypic transition of club cells toward an AT2-like state.

conclusionsThe STING‑regulated Ca²⁺-TGF‑β axis, activated by mitochondrial stress‑induced mtDNA release, is associated with airway remodeling and lung function decline in asthma. PPM1F is a potential biomarker for asthma severity and recurrent exacerbations; targeting STING or PPM1F may offer new therapeutic strategies for severe asthma. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Airway RemodelingAsthmaCalciumMembrane ProteinsTransforming Growth Factor betaAnimalsFemaleHumansLungMaleMiceMice, KnockoutMultiomicsSignal TransductionSTING ProteinCalciumMembrane ProteinsSting1 protein, mouseSTING ProteinTransforming Growth Factor betaAsthmaCalcium signalingMulti-omicsPPM1FSTINGTGF-β

Identifiers

PMID42608700
PMCPMC13479581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.